Drug intelligence / Profile preview

mogroside

Development stage
Unknown
Lead developer
Guangxi Normal University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Mogroside (specifically referring to the family of mogrosides, with mogroside V being the most prominent) is a natural cucurbitane-type tetracyclic triterpenoid glycoside extracted from the fruit of *Siraitia grosvenorii* (monk fruit or Luo Han Guo). Primarily known as a high-intensity, non-caloric sweetener, mogroside is also being developed as a therapeutic agent and dietary supplement due to its anti-inflammatory, antioxidant, and metabolic properties. It is currently under clinical investigation by Guangxi Normal University for the treatment of delayed-onset muscle soreness (DOMS) and has been studied in Phase II trials for chronic hepatitis C. Mogroside exerts its therapeutic effects through multiple pathways, including the activation of the AMP-activated protein kinase (AMPK) and Nrf2 antioxidant pathways, inhibition of the NF-κB inflammatory cascade, and direct agonism of the beta-2 adrenergic receptor (ADRB2) and Toll-like receptor 4 (TLR4). It also acts as an agonist of the sweet taste receptors TAS1R2/TAS1R3 and inhibits maltase-glucoamylase to lower blood glucose levels.

Brand names
PureLo
Other names
Luo Han Guo extractSiraitia grosvenorii extractmogrosidesmonk fruit extract
02

Targets

ADRB2 (β2)Sucrase-IsomaltaseTAS1R2 (Taste receptor type 1 member 2)TAS1R3 (Sweet taste receptor T1R3 subunit)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on mogroside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mogroside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call